Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda

NCT01284946 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Porphyria Cutanea Tarda

Interventions

DRUG: Exjade

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]